TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
26,262
|
44,468
|
39,085 |
| Financial expenses |
9
|
3
|
22 |
| Earnings before taxes |
-38,448
|
-55,447
|
-42,278 |
| EBITDA |
-38,655
|
-56,463
|
-43,153 |
| Total assets |
54,140
|
62,962
|
86,658 |
| Current assets |
52,265
|
60,441
|
84,356 |
| Current liabilities |
8,161
|
18,355
|
22,627 |
| Equity capital |
45,979
|
44,607
|
64,031 |
| - share capital |
8,040
|
3,949
|
3,328 |
| Employees (average) |
33
|
39
|
43 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
84.9%
|
70.8%
|
73.9% |
| Turnover per employee |
796
|
1,140
|
909 |
| Profit as a percentage of turnover |
-146.4%
|
-124.7%
|
-108.2% |
| Return on assets (ROA) |
-71.0%
|
-88.1%
|
-48.8% |
| Current ratio |
640.4%
|
329.3%
|
372.8% |
| Return on equity (ROE) |
-83.6%
|
-124.3%
|
-66.0% |
| Change turnover |
-19,008
|
2,610
|
18,360 |
| Change turnover % |
-42%
|
6%
|
89% |
| Chg. No. of employees |
-6
|
-4
|
11 |
| Chg. No. of employees % |
-15%
|
-9%
|
34% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.